Navigation Links
Tunnell Consulting to Partner with Pharma Quality and Compliance Expert Dr. Ali Afnan
Date:1/22/2013

King of Prussia, PA (PRWEB) January 22, 2013

Tunnell Consulting, Inc. today announced that it has formed a partnership with Ali Afnan, PhD, President of Step Change Pharma, a life sciences consultancy working at the intersection of regulatory compliance and pharmaceutical science.

An expert in compliance and quality, Dr. Afnan was recruited in 2003 by the FDA’s Center for Drug Evaluation and Research (CDER) to join the agency’s Process Analytical Technology (PAT) and Drug Product Quality initiatives. As a member of the PAT steering team and as the science policy advisor to the Office of Pharmaceutical Science, he co-authored the agency’s PAT Guidance and helped draft its most recent guidance on process validation.

“Dr. Afnan’s experience at the FDA enables him to provide life sciences clients with an invaluable perspective on technical and regulatory compliance matters. His demonstrated expertise in compliance, Quality by Design and pharmaceutical science complements Tunnell’s longstanding strengths in those critical areas,” said Conrad J. Heilman, Jr., PhD, President and CEO of Tunnell. “As partners, our combined technical skills and regulatory compliance knowledge will offer both Tunnell and Step Change clients’ unparalleled resources for achieving excellence in their operations.”

“I am delighted to partner with Tunnell, with its proven methodologies and long track record of delivering sustainable solutions to leading pharmaceutical companies,” said Dr. Afnan. “Together we will be able to help clients succeed in an increasingly science-driven regulatory environment where compliance and quality have become essential elements of competitiveness.”

The recipient of several FDA and CDER awards, Dr. Afnan left the agency in 2010 and founded Step Change. Dr. Afnan was the recipient of the 2012 IPS Medal for contributions to Industrial Pharmacy from International Pharmaceutical Federation, and he is a frequent speaker at major industry conferences.

About Tunnell Consulting
Founded in 1962 and serving many of the world’s leading life sciences firms and government agencies, Tunnell Consulting, Inc. integrates strategic, technical and regulatory compliance skills to design and implement sustainable solutions that exactly meet client needs. With deep industry knowledge, extensive scientific and compliance credentials, and superior measurable results, we consistently boost the operating performance of each unique client we serve.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10328058.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
2. A leading Massachusetts-based IT and Life Sciences staffing and consulting firm has opened two new offices in the Ohio Valley
3. No on Prop. 37: French Rat Study Author Made Reporters Sign Confidentiality Agreements Prohibiting them from Consulting Independent Scientific Experts
4. EAS Consulting Group Realigns Its Management for Growth
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
7. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
8. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
9. Pittcon and Food Safety Tech Announce Strategic Conference Partnership
10. Direct Marketing Partners Wins Sales Lead Management’s “Most Influential” in 2012
11. RegLink News Partners with FOI Services on Off-Label Use Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... and MENLO PARK, Calif. , ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on ... that it will present at the 18 th ... 8, 2016 at 10:00 a.m. EST in New ... DelMar,s president and CEO, will provide an update on the ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... & Investor Conference 2016, to be held February 8-9, ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, taking ... February 10-11, 2016. James Sapirstein , Chief ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
(Date:2/4/2016)... , February 4, 2016 Strasbourg, ... (ABL), Inc. --> Strasbourg, France , ... --> PharmaVentures is pleased to announce that it acted ... biopharmaceutical manufacturing unit in Strasbourg, France , ... --> --> Transgene (Euronext: TNG), ...
Breaking Biology Technology:
(Date:1/7/2016)... Jan. 7, 2016 Various factors have ... products such as biologics and biosimilars. Some of ... healthcare expenditure, growing demand for cost-effective alternatives, growing ... Biosimilars are similar versions of their corresponding patented ... their quality, safety, and efficacy. The global biosimilars ...
(Date:1/6/2016)... Calif. , Jan. 6, 2016  Varam Capital, ... as their trusted partner to deliver advanced authentication solutions ... financial services to the poor. A loan of a ... their lives, giving them the ability to purchase livestock ... to make clothing, or stock for a local store. ...
(Date:1/6/2016)...   A&D Medical , a global leader in ... be unveiling a new line of personal mobile health ... UltraConnect – at CES 2016, with the introduction of its ... monitors. ... upper arm wireless blood pressure monitors represent the launch ...
Breaking Biology News(10 mins):